Drug recall · May 20, 2020
Finasteride Plus 1.25 mg Capsule recall
Why: Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
- Lots / codes
Lot #02-27-2020:04@11, Exp. August 25, 2020.
- Quantity
- 7260 capsules
- Company
- MasterPharm LLC, South Richmond Hill, NY
- Distribution
- Nationwide in the U.S.
- Initiated
- April 14, 2020 · Voluntary: Firm initiated
- Classified
- May 19, 2020
- Reported
- May 20, 2020
- Ended
- September 7, 2023
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Finasteride
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.